Skip to content

Efficacy of a Habit Reversal Treatment on Tic-symptoms

Within Subject Design on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents With Tics

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02190383
Enrollment
50
Registered
2014-07-15
Start date
2013-11-30
Completion date
2017-08-31
Last updated
2017-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic-Disorder

Keywords

Tic-Disorder, Tourette-Disorder, Habit Reversal Training

Brief summary

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme in children and adolescents aged 8 to 18 years with tic disorders.

Detailed description

The main purpose of this study is to evaluate the efficacy of a habit reversal based treatment programme for children and adolescents with tic disorders. This habit reversal treatment programme was developed at the Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne and has already been evaluated in a pilot-study (Woitecki & Döpfner, 2011, 2012).

Interventions

awareness training, competing response training

Sponsors

University of Cologne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 8-18 years * Diagnosis of chronic motor or vocal Tic (F95.1) or Tourette-Syndrome (F95.2) * YGTSS total score F95.2\>13, F95.1\>9 * Tics are the main problems * IQ\>80 * If medication, then has been stable for at least one months in medicated patients * No change in medication treatment is planned * Ability to participate in weekly outpatient treatment * Acceptance of randomization

Exclusion criteria

* Diagnosis of Autism Spectrum Disorder or Psychosis * Parallel continuous psychotherapy of tics or comorbid

Design outcomes

Primary

MeasureTime frameDescription
Change in Symptom Checklist for Tic-Symptoms (FBB-TIC), parent ratingBaseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)The FBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents

Secondary

MeasureTime frameDescription
Change in Symptom Checklist for Tic-Symptoms, clinical ratingBaseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24 weeks (T3)The Checklist is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by clinicians
Change of comorbid ADHD Symptoms (FBB/SBB-ADHD), parent, teacher and self-ratingT0, after 8 weeks (T1), 24weeks (T3)The Symptom Checklist for Attention Deficit/Hyperactivity Disorder (FBB-/SBB-ADHS) assess all symptom criteria according to DSM IV and ICD-10.
Change of comorbid OCD Symptoms (ZWIK-E), parent-ratingT0, after 8 weeks (T1), 24 weeks (T3)The ZWIK assess OCD criteria.
Change in Symptom Checklist for Tic-Symptoms (FBB-/SBB-TIC), Teacher-/self-ratingBaseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)The SBB-TIC is used to assess Tic-Symptoms according to DSM-IV and ICD-10 rated by parents
Change in Tic-Symptoms (YGTSS-TIC), overall scoreBaseline (T0), after 8 weeks (T1), 16 weeks (T2) and 24weeks (T3)The YGTSS is used to assess Tic-Symptoms in a semi structured interview with parents and patients
Change in Tic-Symptoms (observation)Between T1 and T3 up to 16 weeks, during each session/weekTic symptoms are observed through video tapes and are rated through clinicians.
Change in self-esteem (Harter-Scale-SBB)(self rating)T0, after 8 weeks (T1), 24weeks (T3)The Harter-Scale is used to assess self-esteem
Change of comorbid Symptoms (CBCL/TRF/YSR), parent-/teacher-/self-ratingT0, after 8weeks (T1), 24weeks (T3)The CBCL, TRF and YSR assess a variation of different criteria.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026